Scarica l'app Stockscreener
8.34
8.27%
0.58
Precedente Chiudi:
$7.76
Aprire:
$8.16
Volume 24 ore:
650.21K
Relative Volume:
0.41
Capitalizzazione di mercato:
$405.04M
Reddito:
$217.11M
Utile/perdita netta:
$-651.19M
Rapporto P/E:
-0.642
EPS:
-12.99
Flusso di cassa netto:
$-387.26M
1 W Prestazione:
+21.41%
1M Prestazione:
+3.47%
6M Prestazione:
+0.14%
1 anno Prestazione:
-72.40%
Intervallo 1D:
$7.89
$8.425
Intervallo di 1 settimana:
$6.42
$8.425
Portata 52W:
$5.00
$38.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Confronta DNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
8.3301 | 405.04M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.19 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.14 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.00 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.43 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.08 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo outlines $250M cost reduction target and tools expansion in Q1 2025 update - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - simplywall.st
Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - MSN
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE: DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Stock Titan
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE:DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Scientists Discover Bacteria That Breathes Electricity — A Game-Changer for Green Energy - Securities.io
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Ginkgo Bioworks Earnings Call: Optimism Amid Challenges - TipRanks
How to Take Advantage of moves in (DNA) - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Q1 2025 Earnings Call Transcript - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Reports Strong Q1 2025 Growth - TipRanks
Ginkgo Bioworks Q1 2025 slides: Revenue grows 27% as cost-cutting advances - Investing.com Canada
Ginkgo Bioworks Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Ginkgo Bioworks’ Q1 2025 revenue rises, stock slips - Investing.com Canada
Ginkgo Bioworks (DNA) Surpasses Revenue Expectations with Strong Q1 Performance | DNA Stock News - GuruFocus
Ginkgo Bioworks (DNA) Anticipates Volatility Ahead of Earnings R - GuruFocus
Ginkgo Bioworks Reports First Quarter 2025 Financial Results - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
Ginkgo (DNA) Updates Revenue Projections for FY25 | DNA Stock News - GuruFocus
Ginkgo Bioworks Holdings, Inc. SEC 10-Q Report - TradingView
Ginkgo Bioworks Q1 2025 Financial Results - TradingView
Ginkgo Bioworks Holdings Inc expected to post a loss of $1.77 a shareEarnings Preview - TradingView
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports - Barchart.com
Top 5 Synthetic Biology Public Companies (May 2025) - Securities.io
Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors - marketscreener.com
Natural Food Colors Breakthrough: Ginkgo Achieves 3X Production Efficiency as FDA Plans Synthetic Dye Ban - Stock Titan
Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Shares Climb 28% But Its Business Is Yet to Catch Up - simplywall.st
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN
Ginkgo Bioworks (DNA) to Enhance Automation at Aura Genetics wit - GuruFocus
Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation - PR Newswire
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series - ADVFN
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation - Finansavisen
Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer - marketscreener.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know - MSN
Lobbying Update: $60,000 of GINKGO BIOWORKS INC. lobbying was just disclosed - Nasdaq
Ginkgo Bioworks (DNA): Building Life On Demand - Securities.io
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):